Jaguar Health, Inc. (JAGX)
1.62
-0.42
(-20.59%)
USD |
NASDAQ |
Oct 30, 16:00
1.60
-0.02
(-1.23%)
After-Hours: 20:00
Jaguar Health Enterprise Value : 10.54M for Oct. 30, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 30, 2026 | 10.54M |
| October 29, 2026 | 10.68M |
| October 28, 2026 | 10.70M |
| October 27, 2026 | 10.75M |
| October 26, 2026 | 10.79M |
| October 23, 2026 | 10.68M |
| October 22, 2026 | 10.72M |
| October 21, 2026 | 10.76M |
| October 20, 2026 | 10.87M |
| October 19, 2026 | 10.93M |
| October 16, 2026 | 11.16M |
| October 15, 2026 | 10.76M |
| October 14, 2026 | 10.70M |
| October 13, 2026 | 10.69M |
| October 12, 2026 | 10.77M |
| October 09, 2026 | 10.80M |
| October 08, 2026 | 10.75M |
| October 07, 2026 | 10.83M |
| October 06, 2026 | 10.93M |
| October 05, 2026 | 10.79M |
| October 02, 2026 | 10.61M |
| October 01, 2026 | 10.66M |
| September 30, 2026 | 10.75M |
| September 29, 2026 | 10.88M |
| September 28, 2026 | 10.99M |
| Date | Value |
|---|---|
| September 25, 2026 | 11.27M |
| September 24, 2026 | 11.16M |
| September 23, 2026 | 11.46M |
| September 22, 2026 | 15.60M |
| September 21, 2026 | 10.45M |
| September 18, 2026 | 10.46M |
| September 17, 2026 | 10.47M |
| September 16, 2026 | 10.59M |
| September 15, 2026 | 10.57M |
| September 14, 2026 | 10.79M |
| September 11, 2026 | 10.78M |
| September 10, 2026 | 10.79M |
| September 09, 2026 | 10.91M |
| September 08, 2026 | 11.03M |
| September 04, 2026 | 11.47M |
| September 03, 2026 | 11.71M |
| September 02, 2026 | 11.79M |
| September 01, 2026 | 11.80M |
| August 31, 2026 | 11.94M |
| August 28, 2026 | 11.99M |
| August 27, 2026 | 12.12M |
| August 26, 2026 | 12.25M |
| August 25, 2026 | 12.27M |
| August 24, 2026 | 12.23M |
| August 21, 2026 | 12.13M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Omeros Corp. | 1.494B |
| ANI Pharmaceuticals, Inc. | 1.889B |
| Corcept Therapeutics, Inc. | 8.456B |
| Veru, Inc. | 14.23M |
| Johnson & Johnson | 685.05B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -12.80M |
| Revenue (Quarterly) | 1.225M |
| Total Expenses (Quarterly) | 13.91M |
| EPS Diluted (Quarterly) | -235.46 |
| Gross Profit Margin (Quarterly) | -22.04% |
| Profit Margin (Quarterly) | -1.05K% |
| Earnings Yield | -338.4K% |
| Normalized Earnings Yield | -290670.2 |